Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$15.0 million.

  • Rxo's Cash from Investing Activities fell 2500.0% to -$15.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$71.0 million, marking a year-over-year increase of 9332.71%. This contributed to the annual value of -$71.0 million for FY2025, which is 9332.71% up from last year.
  • According to the latest figures from Q4 2025, Rxo's Cash from Investing Activities is -$15.0 million, which was down 2500.0% from -$13.0 million recorded in Q3 2025.
  • Over the past 5 years, Rxo's Cash from Investing Activities peaked at -$9.0 million during Q4 2021, and registered a low of -$1.0 billion during Q3 2024.
  • For the 5-year period, Rxo's Cash from Investing Activities averaged around -$74.5 million, with its median value being -$14.0 million (2022).
  • Per our database at Business Quant, Rxo's Cash from Investing Activities crashed by 532105.26% in 2024 and then soared by 9873.79% in 2025.
  • Over the past 5 years, Rxo's Cash from Investing Activities (Quarter) stood at -$9.0 million in 2021, then crashed by 100.0% to -$18.0 million in 2022, then decreased by 5.56% to -$19.0 million in 2023, then surged by 36.84% to -$12.0 million in 2024, then dropped by 25.0% to -$15.0 million in 2025.
  • Its Cash from Investing Activities was -$15.0 million in Q4 2025, compared to -$13.0 million in Q3 2025 and -$18.0 million in Q2 2025.